【www.zhangdahai.com--交通运管公文】
【摘要】目的:探讨盐酸坦洛新缓释片加紫苓胶囊治疗慢性前列腺炎的临床治疗效果。方法:60例慢性前列腺炎的患者随机分成两组。A组30例,盐酸坦洛新缓释片0.2mg/次,口服1次/d,紫苓胶囊1.6g/次,口服3次/d,复方新诺明1.0/次,口服2次/d, 4周为一个疗程,连续治疗两个疗程。B组30例,盐酸坦洛新缓释片0.2mg/次,口服1次/d,复方新诺明1.0/次,口服2次/d,4周为一个疗程,连续治疗两个疗程。随访3个月,详细记录治疗过程中的症状、体征、EPS常规和尿常规。结果:A组30例,其中治愈21例(70.00%),显效9例(30.00%);总有效30例(总有效率100.00%);B组30例,其中治愈16例(53.34%),显效14例(46.66%),总有效30例(总有效率100.00%)。A组与B组在治愈率方面有统计学意义,总有效率方面无统计学意义。结论:在应用抗菌素的基础上,盐酸坦洛新治疗慢性前列腺炎有效,与中成药紫苓胶囊合用临床疗效更满意。
【关键词】前列腺炎;抗菌素;盐酸坦洛新;紫苓胶囊
A clinical survey of TamsulosinZiling Jiaonang in the treatment of chronic prostatitis
TAN Xiao-jie XU Gui-linget al.
【Abstract】 Objective To evaluate the validity of Selective adrenoreceptor antagonists (TamsulosinHydrochloride Sustained release Piece) in the treatment of chronic prostatitis. Methods60 cases of chronic prostatitis were randomized to a finasteride treated group A or control group B.Group A was giveTamsulosinHydrochloride Sustained release Piece, Antibiotics and Ziling Jiaonang. Group B being Antibiotics and TamsulosinHydrochloride Sustained release Piece only. Routine treatment was carried out 8 weeks in all of the 60 cases.Results Ingroup A the curative rate was 70.00% .the remarkable effective rate 30.00%.the total effective ratebeing 100.00%. Ingroup B they were 53.34% , 46.66% .seperately the curative rate group B were lower than group A (P
2 结果
本组病例全部得到随访,随访3个月,在整个治疗观察过程中,未发现与盐酸坦洛新有关的药物不良反应,显示了该药良好的安全性及耐受性。患者NIH-CPSI总分、骨盆痛和不适评分、排尿症状评分及生活质量评分均显著下降(P
